Company profile

Established in May 2021, namicin (Shanghai) Biotechnology Co., Ltd. is an emerging innovative biopharmaceutical R & D enterprise. The founding team of the company is composed of Chinese and American scientists and senior managers from top pharmaceutical research institutions and large drug R & D enterprises at home and abroad.

Focusing on the research and development of cutting-edge biological drugs and new vaccines, the company has core technology platforms such as nucleic acid sequence design optimization, delivery system screening and Shengxin prediction optimization. It is establishing and improving a complete biomedical R & D system from target screening, drug design, efficacy evaluation, process amplification to clinical research, and is committed to becoming a domestic leader An international innovative biomedical R & D enterprise with international first-class and independent innovation ability.

The company has received hundreds of millions of yuan of investment from top investment institutions in the industry such as Shanghai biomedical fund.

Address:

1188 LIANHANG Road, Minhang District, Shanghai